Total Liabilities Summary of Amgen Inc.

Amgen Inc.'s latest annual total liabilities in 2023 was 90.92 Billion USD , up 47.94% from previous year.
Amgen Inc.'s latest quarterly total liabilities in 2024 Q2 was 84.98 Billion USD , down -3.38% from previous quarter.
Amgen Inc. reported annual total liabilities of 61.46 Billion USD in 2022, up 12.84% from previous year.
Amgen Inc. reported annual total liabilities of 54.46 Billion USD in 2021, up 1.73% from previous year.
Amgen Inc. reported quarterly total liabilities of 84.98 Billion USD for 2024 Q2, down -3.38% from previous quarter.
Amgen Inc. reported quarterly total liabilities of 83.35 Billion USD for 2024 Q3, down -1.91% from previous quarter.

Annual Total Liabilities Chart of Amgen Inc. (2023 - 1990)

Historical Annual Total Liabilities of Amgen Inc. (2023 - 1990)

Year	Total Liabilities	Total Liabilities Growth
2023	90.92 Billion USD	47.94%
2022	61.46 Billion USD	12.84%
2021	54.46 Billion USD	1.73%
2020	53.53 Billion USD	7.01%
2019	50.03 Billion USD	-7.2%
2018	53.91 Billion USD	-1.46%
2017	54.71 Billion USD	14.58%
2016	47.75 Billion USD	9.79%
2015	43.49 Billion USD	0.61%
2014	43.23 Billion USD	-1.81%
2013	44.02 Billion USD	24.95%
2012	35.23 Billion USD	18.08%
2011	29.84 Billion USD	52.71%
2010	19.54 Billion USD	15.21%
2009	16.96 Billion USD	5.64%
2008	16.05 Billion USD	-4.25%
2007	16.77 Billion USD	13.13%
2006	14.82 Billion USD	67.58%
2005	8.84 Billion USD	-7.04%
2004	9.51 Billion USD	40.2%
2003	6.78 Billion USD	10.0%
2002	6.17 Billion USD	403.33%
2001	1.22 Billion USD	12.98%
2000	1.08 Billion USD	2.94%
1999	1.05 Billion USD	-5.04%
1998	1.11 Billion USD	14.33%
1997	970.9 Million USD	12.99%
1996	859.3 Million USD	12.92%
1995	761 Million USD	5.72%
1994	719.8 Million USD	21.28%
1993	593.5 Million USD	34.7%
1992	440.6 Million USD	31.76%
1991	334.4 Million USD	178.67%
1990	120 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	87.95 Billion USD	-3.26%
2024 Q2	84.98 Billion USD	-3.38%
2024 Q3	83.35 Billion USD	-1.91%
2023 Q1	83.37 Billion USD	35.65%
2023 FY	90.92 Billion USD	47.94%
2023 Q4	90.92 Billion USD	9.71%
2023 Q3	82.87 Billion USD	-0.73%
2023 Q2	83.48 Billion USD	0.14%
2022 Q2	56.87 Billion USD	-2.41%
2022 Q4	61.46 Billion USD	2.35%
2022 FY	61.46 Billion USD	12.84%
2022 Q1	58.28 Billion USD	7.0%
2022 Q3	60.04 Billion USD	5.58%
2021 Q4	54.46 Billion USD	-4.07%
2021 Q1	53.2 Billion USD	-0.62%
2021 Q2	51.52 Billion USD	-3.16%
2021 FY	54.46 Billion USD	1.73%
2021 Q3	56.77 Billion USD	10.19%
2020 Q2	54.35 Billion USD	4.15%
2020 Q4	53.53 Billion USD	-0.26%
2020 Q3	53.67 Billion USD	-1.24%
2020 FY	53.53 Billion USD	7.01%
2020 Q1	52.18 Billion USD	4.3%
2019 Q4	50.03 Billion USD	2.93%
2019 Q2	48.57 Billion USD	-8.63%
2019 Q3	48.6 Billion USD	0.06%
2019 Q1	53.16 Billion USD	-1.39%
2019 FY	50.03 Billion USD	-7.2%
2018 Q2	52.77 Billion USD	-4.99%
2018 FY	53.91 Billion USD	-1.46%
2018 Q4	53.91 Billion USD	1.76%
2018 Q3	52.98 Billion USD	0.4%
2018 Q1	55.54 Billion USD	1.52%
2017 Q4	54.71 Billion USD	13.74%
2017 FY	54.71 Billion USD	14.58%
2017 Q1	47.22 Billion USD	-1.1%
2017 Q2	47.86 Billion USD	1.36%
2017 Q3	48.1 Billion USD	0.5%
2016 Q3	47.37 Billion USD	4.5%
2016 Q2	45.33 Billion USD	-2.36%
2016 Q4	47.75 Billion USD	0.79%
2016 FY	47.75 Billion USD	9.79%
2016 Q1	46.43 Billion USD	6.76%
2015 Q2	43.72 Billion USD	3.01%
2015 Q4	43.49 Billion USD	-0.93%
2015 Q3	43.9 Billion USD	0.4%
2015 Q1	42.44 Billion USD	-1.82%
2015 FY	43.49 Billion USD	0.61%
2014 Q2	45.15 Billion USD	2.01%
2014 Q1	44.26 Billion USD	0.53%
2014 FY	43.23 Billion USD	-1.81%
2014 Q4	43.23 Billion USD	-4.88%
2014 Q3	45.45 Billion USD	0.66%
2013 Q4	44.02 Billion USD	24.57%
2013 Q3	35.34 Billion USD	10.4%
2013 Q2	32.01 Billion USD	-0.41%
2013 Q1	32.14 Billion USD	-8.77%
2013 FY	44.02 Billion USD	24.95%
2012 Q3	35.54 Billion USD	7.76%
2012 Q1	30.37 Billion USD	1.79%
2012 Q2	32.98 Billion USD	8.6%
2012 FY	35.23 Billion USD	18.08%
2012 Q4	35.23 Billion USD	-0.87%
2011 Q1	17.73 Billion USD	-9.27%
2011 FY	29.84 Billion USD	52.71%
2011 Q4	29.84 Billion USD	34.35%
2011 Q3	22.21 Billion USD	4.17%
2011 Q2	21.32 Billion USD	20.26%
2010 Q1	18.02 Billion USD	6.28%
2010 FY	19.54 Billion USD	15.21%
2010 Q2	17.63 Billion USD	-2.2%
2010 Q4	19.54 Billion USD	0.41%
2010 Q3	19.46 Billion USD	10.4%
2009 Q2	17.48 Billion USD	0.38%
2009 FY	16.96 Billion USD	5.64%
2009 Q4	16.96 Billion USD	-6.19%
2009 Q1	17.41 Billion USD	8.44%
2009 Q3	18.08 Billion USD	3.44%
2008 Q1	17.04 Billion USD	1.62%
2008 Q2	17.52 Billion USD	2.86%
2008 FY	16.05 Billion USD	-4.25%
2008 Q3	17.16 Billion USD	-2.07%
2008 Q4	16.05 Billion USD	-6.46%
2007 Q3	16.54 Billion USD	0.27%
2007 Q2	16.5 Billion USD	28.37%
2007 FY	16.77 Billion USD	13.13%
2007 Q1	12.85 Billion USD	-13.28%
2007 Q4	16.77 Billion USD	1.35%
2006 Q1	13.92 Billion USD	57.4%
2006 Q4	14.82 Billion USD	-0.28%
2006 FY	14.82 Billion USD	67.58%
2006 Q2	14.44 Billion USD	3.77%
2006 Q3	14.86 Billion USD	2.88%
2005 Q3	8.6 Billion USD	1.71%
2005 Q4	8.84 Billion USD	2.84%
2005 FY	8.84 Billion USD	-7.04%
2005 Q1	8.38 Billion USD	-11.94%
2005 Q2	8.45 Billion USD	0.92%
2004 Q2	6.64 Billion USD	3.76%
2004 Q1	6.4 Billion USD	-5.59%
2004 FY	9.51 Billion USD	40.2%
2004 Q4	9.51 Billion USD	35.88%
2004 Q3	7 Billion USD	5.32%
2003 Q4	6.78 Billion USD	5.86%
2003 FY	6.78 Billion USD	10.0%
2003 Q3	6.41 Billion USD	-0.39%
2003 Q2	6.43 Billion USD	3.38%
2003 Q1	6.22 Billion USD	0.9%
2002 Q3	6.07 Billion USD	42.74%
2002 Q1	4.11 Billion USD	235.68%
2002 Q2	4.25 Billion USD	3.45%
2002 Q4	6.17 Billion USD	1.55%
2002 FY	6.17 Billion USD	403.33%
2001 Q4	1.22 Billion USD	29.66%
2001 Q1	1.04 Billion USD	-3.96%
2001 Q2	958.9 Million USD	-7.98%
2001 Q3	945.5 Million USD	-1.4%
2001 FY	1.22 Billion USD	12.98%
2000 Q2	1.05 Billion USD	11.03%
2000 Q4	1.08 Billion USD	14.69%
2000 Q3	946.1 Million USD	-10.65%
2000 Q1	953.7 Million USD	-9.52%
2000 FY	1.08 Billion USD	2.94%
1999 Q1	1.07 Billion USD	-3.16%
1999 Q2	1.1 Billion USD	2.73%
1999 Q3	1.04 Billion USD	-5.7%
1999 FY	1.05 Billion USD	-5.04%
1999 Q4	1.05 Billion USD	1.23%
1998 Q2	1.09 Billion USD	3.68%
1998 FY	1.11 Billion USD	14.33%
1998 Q1	1.05 Billion USD	8.31%
1998 Q3	1.09 Billion USD	0.71%
1998 Q4	1.11 Billion USD	1.09%
1997 Q2	773.7 Million USD	2.44%
1997 Q3	763 Million USD	-1.38%
1997 FY	970.9 Million USD	12.99%
1997 Q1	755.3 Million USD	-12.1%
1997 Q4	970.9 Million USD	27.25%
1996 FY	859.3 Million USD	12.92%
1996 Q1	613.9 Million USD	-19.33%
1996 Q4	859.3 Million USD	9.97%
1996 Q3	781.4 Million USD	15.68%
1996 Q2	675.5 Million USD	10.03%
1995 Q4	761 Million USD	-1.6%
1995 Q3	773.4 Million USD	1.32%
1995 Q2	763.3 Million USD	6.74%
1995 Q1	715.1 Million USD	-0.65%
1995 FY	761 Million USD	5.72%
1994 Q2	567.5 Million USD	-5.72%
1994 FY	719.8 Million USD	21.28%
1994 Q1	601.9 Million USD	1.42%
1994 Q4	719.8 Million USD	26.08%
1994 Q3	570.9 Million USD	0.6%
1993 Q1	377.1 Million USD	-14.41%
1993 Q3	521.9 Million USD	12.87%
1993 Q4	593.5 Million USD	13.72%
1993 FY	593.5 Million USD	34.7%
1993 Q2	462.4 Million USD	22.62%
1992 Q3	471.2 Million USD	9.15%
1992 FY	440.6 Million USD	31.76%
1992 Q4	440.6 Million USD	-6.49%
1992 Q2	431.7 Million USD	6.25%
1992 Q1	406.3 Million USD	21.5%
1991 Q4	334.4 Million USD	10.4%
1991 Q1	116 Million USD	-20.71%
1991 Q3	302.9 Million USD	9.27%
1991 Q2	277.2 Million USD	138.97%
1991 FY	334.4 Million USD	178.67%
1990 FY	120 Million USD	0.0%
1990 Q1	120 Million USD	18.81%
1990 Q2	133.2 Million USD	11.0%
1990 Q4	146.3 Million USD	56.47%
1990 Q3	93.5 Million USD	-29.8%
1989 Q2	96.3 Million USD	113.05%
1989 Q3	86.6 Million USD	-10.07%
1989 Q4	101 Million USD	16.63%
1989 Q1	45.2 Million USD	0.0%

Peer Total Liabilities Comparison of Amgen Inc.

Name	Total Liabilities	Total Liabilities Difference
AstraZeneca PLC	61.95 Billion USD	-46.76%
Biogen Inc.	12.04 Billion USD	-654.828%
Gilead Sciences, Inc.	39.37 Billion USD	-130.907%
MIRA Pharmaceuticals, Inc.	558.09 Thousand USD	-16291333.21%
Scilex Holding Company	274.24 Million USD	-33053.325%
Scilex Holding Company	274.24 Million USD	-33053.325%

Global Stocks Search

Amgen Inc. (AMGN)

Total Liabilities Summary of Amgen Inc.

Annual Total Liabilities Chart of Amgen Inc. (2023 - 1990)

Historical Annual Total Liabilities of Amgen Inc. (2023 - 1990)

Peer Total Liabilities Comparison of Amgen Inc.